0001485003-19-000047.txt : 20190712 0001485003-19-000047.hdr.sgml : 20190712 20190712173150 ACCESSION NUMBER: 0001485003-19-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190710 FILED AS OF DATE: 20190712 DATE AS OF CHANGE: 20190712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacDonald Glen C CENTRAL INDEX KEY: 0001773277 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 19953667 MAIL ADDRESS: STREET 1: 245 FIRST STREET, SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_156296709613910.xml FORM 4 X0306 4 2019-07-10 0 0001485003 Sesen Bio, Inc. SESN 0001773277 MacDonald Glen C C/O SESEN BIO, INC. SUITE 1800 CAMBRIDGE MA 02142 0 1 0 0 Chief Technology Officer Employee Stock Option (Right to Buy) 1.59 2019-07-10 4 A 0 0 1.59 A 2027-10-03 Common Stock 24900.0 102780 D On October 4, 2017, the reporting person was granted an option to purchase 120,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On July 10, 2019, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 24,900 shares. /s/ Richard F. Fitzgerald 2019-07-12